dNovo Bio

About:

Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand.

Top Investors: Y Combinator, Soma Capital, Pioneer Fund, Felicis, Justin Mateen

Description:

Dnovobio is a developer of a direct reprogramming technology intended to create any cell, tissue, or organ on demand. Its company's platform converts skin into functional brain cells.

Total Funding Amount:

$2.7M

Headquarters Location:

San Jose, California, United States

Founded Date:

2018-01-01

Contact Email:

founders(AT)dnovobio.com

Founders:

Cyrus Khajvandi, Ernesto Lujan

Number of Employees:

1-10

Last Funding Date:

2022-01-24

IPO Status:

Private

Industries: